Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Current Opinion in Neurology|April 19, 2015
Using MRI to make informed clinical decisions in multiple sclerosis careRobert A Bermel, Robert T Naismith
The Lancet. Neurology|January 24, 2006
The measurement and clinical relevance of brain atrophy in multiple sclerosisRobert A Bermel, Rohit Bakshi
Neurology|March 11, 2014
Natalizumab to fingolimod washout in patients at risk of PML: when good intentions yield bad outcomesGavin Giovannoni, Robert T Naismith
Continuum (Minneapolis, Minn.)|July 20, 2012
MRI in multiple sclerosisRobert A Bermel, Robert J Fox
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Interferon-beta treatment for multiple sclerosisRobert A Bermel, Richard A Rudick
Continuum (Minneapolis, Minn.)|August 7, 2013
Optic neuritis and the evaluation of visual impairment in multiple sclerosisRobert A Bermel, Laura J Balcer
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 26, 2021
Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosisRobert J Fox, Paola Raska, Christian Barro, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 16, 2020
Optical coherence tomography and multiple sclerosis: Update on clinical application and role in clinical trialsJeffrey Lambe, Shiv Saidha, Robert A Bermel
Neurology|December 3, 2020
Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS StudyRobert T Naismith, Robert A Bermel, Christopher S Coffey, et al.
Neuroimaging Clinics of North America|December 11, 2008
The use of MR imaging as an outcome measure in multiple sclerosis clinical trialsRobert A Bermel, Elizabeth Fisher, Jeffrey A Cohen
Pageof 15